REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Paediatric Joint Formulary
Home > Formulary : Paediatric > Recent Decisions > 2020 >

Tuesday 8th September 2020

At the meeting on the 8th September the following decisions were agreed


New Drug Requests

  • Desmopressin oral tablets and oral lyophilisates (TLS Green) for primary nocturnal enuresis

  • Oxybutynin modified release tablets (TLS Amber no SCP)

  • Ropivacaine (TLS Red)

  • Tapentadol oral solution 20mg/ml (TLS Red)


Shared Care Protocols/TLS changes

New SCPs

Updated SCPs

Other decisions: 


  • In light of oxybutynin modified release approval as TLS Amber no SCP status, it was agreed to change other antimuscarinics to TLS Amber no SCP status also - solifenacin, oxybutynin immediate release, tolterodine